Garrity ER et al. |
Suggested guidelines for the use of tacrolimus in lung-transplant recipients. |
1999 |
J. Heart Lung Transplant. |
pmid:10328140
|
Ruzicka T et al. |
Tacrolimus: the drug for the turn of the millennium? |
1999 |
Arch Dermatol |
pmid:10328199
|
Schmidt RH et al. |
Haemolytic-uraemic syndrome after tacrolimus rescue therapy for cortisone-resistant rejection. |
1999 |
Nephrol. Dial. Transplant. |
pmid:10328486
|
Kohyama T et al. |
A potent immunosuppressant FK506 inhibits IL-8 expression in human eosinophils. |
1999 |
Mol. Cell Biol. Res. Commun. |
pmid:10329481
|
Tian J and Karin M |
Stimulation of Elk1 transcriptional activity by mitogen-activated protein kinases is negatively regulated by protein phosphatase 2B (calcineurin). |
1999 |
J. Biol. Chem. |
pmid:10329725
|
Nakamura H et al. |
Induction of autologous graft-versus-host disease after autologous peripheral blood stem cell transplantation. |
1999 |
J. Allergy Clin. Immunol. |
pmid:10329849
|
Dresske B et al. |
Synergistic impact of "WOFIE" on the immunosuppressive potency of FK 506 in a heterotopic heart transplantation model in the rat. |
1999 |
Transplant. Proc. |
pmid:10331001
|
Okamoto H |
The CD38-cyclic ADP-ribose signaling system in insulin secretion. |
1999 |
Mol. Cell. Biochem. |
pmid:10331647
|
Iwamoto H et al. |
Inhibitory effects of FK506 on the development of experimental allergic/immune-mediated blepharoconjunctivitis in Lewis rats by systemic but not by topical administration. |
1999 |
Graefes Arch. Clin. Exp. Ophthalmol. |
pmid:10333108
|
Henley SA et al. |
Lipids increase after solitary pancreas transplantation. |
1999 |
Diabetes Care |
pmid:10333952
|
van den Berg JW et al. |
New immunosuppressive drugs and lung transplantation: last or least? |
1999 |
Thorax |
pmid:10335012
|
Shirbacheh MV et al. |
Pharmacokinetics of intra-arterial delivery of tacrolimus to vascularly isolated rabbit forelimb. |
1999 |
J. Pharmacol. Exp. Ther. |
pmid:10336506
|
Gold BG et al. |
Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. |
1999 |
J. Pharmacol. Exp. Ther. |
pmid:10336507
|
Steg RE et al. |
Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation. |
1999 |
Bone Marrow Transplant. |
pmid:10338054
|
Ferrand-Drake M et al. |
Mitochondrial permeability transition induced DNA-fragmentation in the rat hippocampus following hypoglycemia. |
1999 |
Neuroscience |
pmid:10338300
|
Conboy IM et al. |
Calcineurin and vacuolar-type H+-ATPase modulate macrophage effector functions. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10339586
|
Ma D and Carlow CK |
Molecular characterization of FKBP13 from filarial parasites. |
1999 |
Mol. Biochem. Parasitol. |
pmid:10340490
|
Ruddy SB et al. |
Design and characterization of a surfactant-enriched tablet formulation for oral delivery of a poorly water-soluble immunosuppressive agent. |
1999 |
Int J Pharm |
pmid:10341307
|
Uchio E et al. |
Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behçet's disease and Vogt-Koyanagi-Harada's disease. |
1999 Mar-Apr |
Clin. Exp. Rheumatol. |
pmid:10342043
|
Moffatt SD et al. |
Potential for improved therapeutic index of FK506 in liposomal formulation demonstrated in a mouse cardiac allograft model. |
1999 |
Transplantation |
pmid:10342309
|